BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park J, Kim J, Kim S, Jung JH, Jang M, Park S, Lee M, Kim H, Suk KT, Kim DJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022;10:1288. [DOI: 10.3390/biomedicines10061288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Kasztelan-szczerbinska B, Rycyk-bojarzynska A, Szczerbinska A, Cichoz-lach H. Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview. Nutrients 2023;15:760. [DOI: 10.3390/nu15030760] [Reference Citation Analysis]
2 Tsomidis I, Notas G, Xidakis C, Voumvouraki A, Samonakis DN, Koulentaki M, Kouroumalis E. Enzymes of Fibrosis in Chronic Liver Disease. Biomedicines 2022;10. [PMID: 36551935 DOI: 10.3390/biomedicines10123179] [Reference Citation Analysis]
3 Li ZJ, Gou HZ, Zhang YL, Song XJ, Zhang L. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. World J Gastroenterol 2022; 28(44): 6213-6229 [DOI: 10.3748/wjg.v28.i44.6213] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nalbantoglu I, Misdraji J. Approach to the liver biopsy diagnosis of adult cholangiopathies. Diagnostic Histopathology 2022. [DOI: 10.1016/j.mpdhp.2022.10.004] [Reference Citation Analysis]
5 Wu S, Cao Y, Lu H, Qi X, Sun J, Ye Y, Gong L. Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy. Biomedicine & Pharmacotherapy 2022;153:113512. [DOI: 10.1016/j.biopha.2022.113512] [Reference Citation Analysis]
6 Humphry N. Recent Findings in the Gut-Liver Axis and Associated Disease Therapy. EMJ Hepatol 2022. [DOI: 10.33590/emjhepatol/10154221] [Reference Citation Analysis]
7 Shibahara I, Shibahara Y, Hagiwara H, Watanabe T, Orihashi Y, Handa H, Inukai M, Hide T, Yasui Y, Kumabe T. Ventricular opening and cerebrospinal fluid circulation accelerate the biodegradation process of carmustine wafers suggesting their immunomodulation potential in the human brain. J Neurooncol 2022. [PMID: 35802230 DOI: 10.1007/s11060-022-04078-5] [Reference Citation Analysis]